Test
NIPT (5 Chromosomes)
NIPT
Non-invasive screening for trisomy 21/18/13 and sex-chromosome aneuploidy from maternal blood (≥10 weeks).
OnePLUS laboratory & diagnostics
Tests & Packages
Explore the OnePLUS directory of diagnostic tests and health checkup packages. Find available parameters, sample requirements, and preparation details.
999 available tests & packages
999 matching entries
Showing 217–240
Test
NIPT (All Chromosomes)
NIPT All
Non-invasive screening for trisomy 21/18/13 and sex-chromosome aneuploidy from maternal blood (≥10 weeks).
Test
Papp - A
PAPP-A
Aneuploidy and pre-eclampsia risk screening.
Test
Penta Screening
Penta Screen
Second-trimester screening for aneuploidy and neural-tube defects (five markers).
Test
Placental Growth Factor (PlGF)
PlGF
Pre-eclampsia – rule-out / prediction (PlGF, with sFlt-1 ratio).
Test
Procedure + WES + CNV + QF PCR + MCC (Cvs)
WES+CNV (CVS)
Copy-number variants beyond karyotype resolution – developmental delay, congenital anomalies, fetal anomalies, miscarriage tissue.
Test
Prothrombin Gene Mutation
Factor II
Myeloproliferative neoplasm (JAK2); inherited thrombophilia / folate-pathway variants.
Test
QF PCR+MCC+Microarray (CMA) 750K
QF-PCR+CMA
Copy-number variants beyond karyotype resolution – developmental delay, congenital anomalies, fetal anomalies, miscarriage tissue.
Test
QF-PCR
QF-PCR
Cause-of-loss / aneuploidy testing on products of conception (recurrent miscarriage work-up) or prenatal samples.
Test
Quadruple Marker (Integrated)
Quad Marker
Second-trimester (15–20 wk) screening for Down syndrome, Edwards syndrome and neural-tube defects.
Test
Quadruple Test
Quad Test
5 listed parameters
INHIBIN A · Attachment · HCG
Test
Sca(Spinocerebellar Ataxia) Panel
SCA Panel
Genetic diagnosis of spinocerebellar ataxia (repeat-expansion panel).
Test
Single Variant Analysis
SVA
Targeted genetic testing – confirmation of a known or suspected familial variant, carrier screening, prenatal diagnosis.
Test
Thalassemia Gene Mutation Trio
Thal Trio
Targeted genetic testing – confirmation of a known or suspected familial variant, carrier screening, prenatal diagnosis.
Test
Tissue Karyotyping
Karyotype
3 listed parameters
CHROMOSOME ANALYSIS (KARYOTYPE) COUPLE BLOOD · CYTO_COMMENTS · Vip_BloodCulture
Test
Triple Test
Triple Test
4 listed parameters
Attachment · HCG · AFP
Test
Whole Exome Sequencing
WES
2 listed parameters
COMMENT · NX GEN WHOLE EXOME SEQUENCING - THERMOFISHER
Test
Whole Exome Sequencing Trio
WES Trio
3 listed parameters
Nx GEN WHOLE EXOME SEQUENCING TRIO · SPECIMEN_FATHER · SPECIMEN_MOTHER
Test
AFP (Alpha Fetoprotein)
AFP
1 listed parameter
AFP
Test
Beta 2 Microglobulin (Serum)
β2M
Prognosis in myeloma / lymphoma; renal tubular function.
Test
CA 125
CA-125
1 listed parameter
Growth Hormone
Test
CA 15.3 (Breast Cancer Marker)
CA 15.3
1 listed parameter
CA 15.3; BREAST CANCER MARKER, SERUM
Test
CA 27.29
CA 27.29
Tumour-marker monitoring (not for screening alone): ovary (CA-125), breast (CA 15.3/27.29), pancreas/GI (CA 19.9, CEA, CA 72.4), liver (AFP, PIVKA-II).
Test
CA 72.4
CA 72.4
Tumour-marker monitoring (not for screening alone): ovary (CA-125), breast (CA 15.3/27.29), pancreas/GI (CA 19.9, CEA, CA 72.4), liver (AFP, PIVKA-II).